Members Co., Ltd. (TYO:2130)

Ligand Pharmaceuticals Balance Sheet

Financials in millions JPY. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	4,015	3,776	4,479	5,226	4,140
Cash & Short-Term Investments	4,015	3,776	4,479	5,226	4,140
Cash Growth	6.33%	-15.70%	-14.29%	26.23%	32.91%
Receivables	3,791	3,847	3,388	3,075	2,842
Inventory	35.19	38	68	48	31
Prepaid Expenses	-	177	224	215	167
Other Current Assets	193.28	127	11	11	8
Total Current Assets	8,034	7,965	8,170	8,575	7,188
Property, Plant & Equipment	1,503	1,275	1,267	951	743
Long-Term Investments	-	1,742	1,341	374	269
Goodwill	116.12	116	116	116	116
Other Intangible Assets	13.88	7	10	12	8
Long-Term Deferred Tax Assets	568.63	419	410	375	323
Other Long-Term Assets	1,542	3	1	1	1
Total Assets	11,778	11,527	11,315	10,404	8,648
Accounts Payable	1,023	1,119	1,201	1,068	974
Accrued Expenses	-	1,733	1,301	1,053	855
Current Portion of Leases	541.12	439	360	400	234
Current Income Taxes Payable	228.77	1,556	1,391	1,579	1,422
Current Unearned Revenue	19.56	-	-	-	-
Other Current Liabilities	3,510	241	131	95	285
Total Current Liabilities	5,322	5,088	4,384	4,195	3,770
Long-Term Leases	398.64	276	301	197	157
Other Long-Term Liabilities	249.31	230	256	117	108
Total Liabilities	5,970	5,594	4,941	4,509	4,035
Common Stock	1,058	1,057	1,017	963	910
Additional Paid-In Capital	761.91	393	342	281	228
Retained Earnings	4,629	5,020	5,284	4,606	3,427
Treasury Stock	-698.16	-698	-300	-8	-8
Comprehensive Income & Other	57.8	161	31	53	56
Total Common Equity	5,808	5,933	6,374	5,895	4,613
Shareholders' Equity	5,808	5,933	6,374	5,895	4,613
Total Liabilities & Equity	11,778	11,527	11,315	10,404	8,648
Total Debt	939.75	715	661	597	391
Net Cash (Debt)	3,075	3,061	3,818	4,629	3,749
Net Cash Growth	0.46%	-19.83%	-17.52%	23.47%	41.21%
Net Cash Per Share	240.70	234.92	286.77	347.44	283.83
Filing Date Shares Outstanding	12.77	12.77	13.1	13.25	12.97
Total Common Shares Outstanding	12.77	12.77	13.09	13.13	12.89
Working Capital	2,712	2,877	3,786	4,380	3,418
Book Value Per Share	454.95	464.71	487.08	449.05	357.87
Tangible Book Value	5,678	5,810	6,248	5,767	4,489
Tangible Book Value Per Share	444.77	455.07	477.45	439.30	348.25
Order Backlog	-	1,385	1,384	692.98	751.82

Source: S&P Global Market Intelligence. Standard template. Financial Sources.